Mitsubishi Chemical Group에 대한 매도 수량은 투자자에게 Mitsubishi Chemical Group의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Mitsubishi Chemical Group (OTC:MTLHY) 주식, 공매도 수량 보고

MITSUBISHI CHEMICAL

Mitsubishi Chemical Group Corp is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into three segments based on product. The Industrial Materials segment, which generates the majority of revenue, sells chemicals and polymers, including industrial gases, petrochemicals, thermoplastics, polyethylene, and polypropylene. The Performance Products segment sells electronics and designed materials, including LED lighting and equipment, specialty chemicals, polyester and industrial films, and fibers. The Health Care segment sells pharmaceuticals to treat autoimmune diseases, diabetes and kidney diseases, central nervous system treatments, and vaccines. The majority of revenue comes from Japan.

Asia

Government

Regulations

Eurozone

Politics

Global

Markets

AHKSY

BASFY

MTLHY

SABRY

중국은 미국과 유럽 연합에서 만든 플라스틱에 대한 새로운 반덤핑 조사를 시작하면서 서구와의 현재 진행 중인 경제 전쟁에서 새로운 단계를 밟았다. 이번 조치는 최근 조 바이든 대통령이 주도한 중국산 수입품에 대한 관세 인상 등 서방 국가들의 최근 보호주의 조치에 대한 보복 조치로 읽힐 수 있다.

중국, 바이든의 관세에 대응하여 새로운 플라스틱 수입 조사로 반격: 6개 주식이 피해 우려

MITSUBISHI CH GRP U/ADR by Mitsubishi Chemical Group Corporation

Mitsubishi Chemical Group Corp

Air Products and Chemicals' (APD) fourth-quarter earnings beat analysts' estimates, but the specialty chemicals producer lagged on revenues. However, given a remarkable track record of 41 consecutive years of dividend growth, is APD an ideal investment this week? Read more… Specialty chemicals manufacturer Air Products and Chemicals, Inc.'s (<a href="https://stocknews.com/stock/APD/">APD</a>) fiscal 2023 fourth-quarter earnings surpassed analysts' estimates but missed on revenues. The company reported quarterly adjusted earnings of $3.15 per share, beating the consensus estimate of $3.11 per share. This compares to EPS of $2.89 a year earlier.
However, APD's fourth-quarter revenue came in at $3.19 billion, lower than analysts' expectations of $3.35 billion. The revenue compared to $3.57 billion in the same period last year. Further, the company missed the consensus revenue estimates in three of the trailing four quarters.
For the full year fiscal 2024, the company expects adjusted EPS of $12.80-$13.10, an increase of 13% at the midpoint from the prior year's value. For the fiscal 2024 first quarter, Air Products' adjusted EPS guidance is $2.90 to $3.05, up 13% at the midpoint over fiscal 2023 first quarter adjusted EPS.
Also, APD anticipates capital expenditures of $5 billion to $5.5 billion for the full-year 2024.
Yesterday, APD's shares <a href="https://www.cnbc.com/2023/11/07/air-products-has-a-bad-quarter-jim-cramer-favors-rival-linde-instead.html">slumped more than 10%</a> after the company released weaker-than-expected revenue for its fourth quarter of 2023. "It was a very bad quarter," Jim Cramer said, pointing to the company's weak forward guidance compared to competitor Linde's (<a href="https://stocknews.com/stock/LIN/">LIN</a>) overall upbeat results last month.
However, the company continued to increase the dividend, paying out nearly $1.50 billion to its shareholders during the fiscal 2023. APD raised the quarterly dividend by 8% to $1.75 per share in January, marking the 41st consecutive year of increases. Its annual dividend of $7 translates to a yield of 2.75% at the current share price. Its four-year average dividend yield is 2.15%.
Further, the company's dividend payouts have grown at a CAGR of 9.9% over the past three years and 10.1% over the past five years.
Shares of APD have plunged 9.4% over the past month and 13.9% over the past six months to close the last trading session at $254.46. Also, the stock has declined 17% year-to-date.
Here's what could influence APD's performance in the upcoming months:
Positive Developments
On November 6, APD announced that it will build, own, and operate a state-of-the-art carbon capture (CO2) treatment facility at its existing hydrogen production plant in Rotterdam, the Netherlands.
The facility is anticipated to be on-stream in 2026, and the resulting blue hydrogen product will serve ExxonMobil's (Esso) Rotterdam refinery and additional customers through Air Products' hydrogen pipeline network system. It might take a while to realize gains from this blue hydrogen plant as it's likely to be operating in 2026.
On October 30, the company announced that it would supply two main cryogenic heat exchanger (MCGE) replacements for the PETRONAS LNG Complex in Bintulu, Sarawak, Malaysia.
These replacements are part of an extension program implemented to extend the life and continue the superior performance and high reliability of the MLNG Dua LNG facility in Bintulu. This will be the second and third MCHE replacements provided by Air Products at the facility, following the original units completed almost three decades of reliable service.
Mixed Financials  
APD's sales declined 10.6% year-over-year to $3.19 billion for the fourth quarter ended September 30, 2023. However, its non-GAAP operating income increased 5.5% from the year-ago value to $738.60 million. The company's adjusted EBITDA came in at $1.26 billion, up 10% from the previous year's quarter.
Furthermore, Non-GAAP net income attributable to Air Products grew 12.4% from the prior year's quarter to $2.56 billion, and its non-GAAP EPS was $3.15, an increase of 10.5% year-over-year. Its <a href="https://www.investopedia.com/terms/t/total-liabilities.asp#:~:text=Total%20liabilities%20are%20the%20combined%20debts%20that%20an%20individual%20or,%2Dterm%2C%20and%20other%20liabilities.">total liabilities</a> stood at $16.34 billion as of September 30, 2023, compared to $13.49 billion as of September 30, 2022.
Favorable Analyst Estimates
Analysts expect APD's revenue to increase 0.5% year-over-year to $3.19 billion for the fiscal 2024 first quarter ending December 2023. The consensus earnings per share estimate of $2.98 for the ongoing quarter indicates a 13.1% rise year-over-year. Moreover, the company has topped the consensus EPS estimates in three of the trailing four quarters.
For the fiscal year ending September 2024, analysts expect APD's revenue and EPS to increase 7.2% and 12.8% year-over-year to $13.50 billion and $12.98, respectively. The company's revenue and EPS for fiscal year 2025 are expected to grow 9.5% and 9.3% year-over-year to $14.78 billion and $14.19, respectively.
Mixed Profitability
APD's trailing-12-month gross profit margin of 29.90% is 5.2% higher than the industry average of 28.43%. Also, the stock's trailing-12-month EBITDA margin and net income margin of 32.52% and 18.26% are 84.8% and 210.5% higher than the industry averages of 17.60% and 5.88%, respectively.
However, the stock's trailing-12-month asset turnover ratio of 0.43x is 41% lower than the industry average of 0.72x.
Elevated Valuation
In terms of forward non-GAAP P/E, APD is currently trading at 19.74x, 39.3% higher than the industry average of 14.18x. Likewise, the stock's forward EV/Sales and Price/Sales of 4.93x and 4.17x are significantly higher than the industry average of 1.43x and 1.06x, respectively.
In addition, the stock's forward Price/Cash Flow multiple of 12.97 is 79.6% higher than the industry average of 7.22.
POWR Ratings Reflect Uncertainty
APD's mixed fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall C rating, equating to Neutral in our proprietary rating system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.
Our proprietary rating system also evaluates each stock based on eight distinct categories. The stock has a C grade for Quality, consistent with its mixed profitability.
In addition, APD has a C grade for Growth, in sync with its mixed financial performance in the last reported quarter.
Within the <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry, APD is ranked #43 out of 83 stocks.
Beyond what I have stated above, we have also given APD grades for Sentiment, Stability, Value, and Momentum. Get all APD's POWR Ratings <a href="https://stocknews.com/stock/APD/">here</a>.
Bottom Line  
APD's earnings beat analysts' expectations in the last reported quarter but missed out on revenues. Despite decent earnings and revenue growth in the upcoming quarters, the stock's stretched valuation is concerning. APD's stock is currently trading below its 50-day and 200-day moving averages of $287.83 and $287.70, respectively, indicating a downtrend.
Given its mixed financials, mixed profitability, stretched valuation, and bleak near-term prospects, it could be wise to hold APD and wait for a better entry point in the stock.
Stocks to Consider Instead of Air Products and Chemicals, Inc. (APD)
Given its uncertain short-term prospects, the odds of APD outperforming in the weeks and months ahead are compromised. However, there are many industry peers with much more impressive POWR Ratings. So, consider these three A-rated (Strong Buy) stocks from the <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry instead:
Mitsubishi Chemical Holdings Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>)
Kuraray Co., Ltd. (<a href="https://stocknews.com/stock/KURRY/">KURRY</a>)
ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>)
To explore more A and B-rated chemical stocks, <a href="https://stocknews.com/category/chemicals/">click here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
APD shares were trading at $256.05 per share on Wednesday morning, up $1.59 (+0.62%). Year-to-date, APD has declined -15.40%, versus a 15.66% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Mangeet Kaur Bouns</h2> <img src='https:/wp-content/uploads/2022/01/Mangeet-Kaur-Bouns_Image-4.jpg' style="float:left; padding:5px;width:125px;">Mangeet's keen interest in the stock market led her to become an investment researcher and financial journalist. Using her fundamental approach to analyzing stocks, Mangeet's looks to help retail investors understand the underlying factors before making investment decisions.<a href="https://stocknews.com/authors/?author=mangeet-kaurbouns">More...</a>The post <a href=https://stocknews.com/news/apd-mtlhy-kurry-cdxc-lin-is-air-products-chemicals-apd-a-potential-buy-this/>Is Air Products & Chemicals (APD) a Potential Buy This Week?</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Is Air Products & Chemicals (APD) a Potential Buy This Week?

The chemical industry demonstrates remarkable resilience, driven by the robust demand for chemicals used across industries to transform raw materials and precursors into valuable commercial products that serve societal needs. Therefore, fundamentally strong chemical stocks Fuchs SE (FUPBY), Mitsubishi Chemical Group Corporation (MTLHY), and NewMarket Corporation (NEU) could be solid buys to build up your portfolio. Read on… The chemical industry is poised for significant expansion, propelled by robust demand across crucial sectors. As the industry seems to be in a bright spot, loading up on quality chemical stocks Fuchs SE (<a href="https://stocknews.com/stock/FUPBY/">FUPBY</a>), Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>), and NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>) could be wise.
The U.S. chemical industry, fundamental to domestic manufacturing, produces an expansive array of end-products, ranging from common consumer necessities to essential industrial manufacturing and construction elements. This makes their influence profound on micro and macroeconomic scales.
The U.S. chemical industry, contributing over a quarter to the <a href="https://www.cisa.gov/sites/default/files/2023-02/chemical_sector_profile_final_508_2022_0.pdf">nation's GDP</a>, has recently exhibited robust financial performance – reaching levels not seen in more than two decades, thanks to high demand.
Additionally, fresh governmental policies and incentives encouraging investments in energy transition have fostered increased manufacturing activity reliant on chemicals and materials. It is pertinent to note that the chemical industry underpins over 75% of <a href="https://www2.deloitte.com/us/en/insights/industry/oil-and-gas/chemical-industry-outlook.html">emission-reducing technologies</a>.
Moreover, <a href="https://www2.deloitte.com/us/en/pages/energy-and-resources/articles/future-of-digitalization-in-the-chemical-industry.html">digital technology</a> is transforming the strategic landscape for chemical manufacturers. Chemical producers will likely employ various digital tools to innovate materials and expedite cost-effective formulations by evaluating, optimizing, and assimilating ingredient recipes and domain knowledge.
The global chemical market is anticipated to reach $6.85 trillion by 2027, growing at a <a href="https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report">CAGR of 7.8%</a>.
Given the industry tailwinds, it's time to examine the fundamentals of the three stocks to buy in the <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry, starting with the third in line.
Stock #3: Fuchs SE (<a href="https://stocknews.com/stock/FUPBY/">FUPBY</a>)
Headquartered in Mannheim, Germany, FUPBY develops, produces, and sells lubricants and related specialties in Europe, the Middle East, Africa, the Asia Pacific, and North and South America.
On September 14, FUPBY opened a new manufacturing facility in Ba Ria-Vung Tau, Vietnam. The company, which has maintained a significant presence in Vietnam since 2013, bolstered its potential in the quickly-growing region by investing approximately €9 million ($9.85 million) in the high-tech plant.
This strategic expansion is expected to empower FUPBY Vietnam to satisfy the escalating demand for lubricants in the area more effectively and to adapt swiftly to the local market requirements.
The inauguration of this high-tech factory signals FUPBY's plans to broaden and diversify its product portfolio in Vietnam, a move coherently reflecting the robust growth opportunities inherent to the country's market.
FUPBY pays an annual dividend of $0.29 per share, translating to a dividend yield of 2.75%. Its four-year average yield is 2.79%. Its dividend payments have grown at CAGRs of 3.9% and 1.7% over the past three and five years, respectively.
FUPBY's trailing-12-month ROCE, ROTC, and <a href="https://www.investopedia.com/terms/r/return_on_total_assets.asp">ROTA</a> are 15.22%, 12.14%, and 10.96% are 96.7%, 122.2%, and 209.7% higher than the industry averages of 7.74%, 5.47%, and 3.54%, respectively. Its trailing-12-month asset turnover ratio of 1.37x is 95.5% higher than the industry average of 0.70x.
In the fiscal third quarter that ended September 30, 2023, FUPBY's sales revenues stood at €876 million ($958.29 million), while its gross profit increased 5.1% year-over-year to €288 million ($315.06 million).
For the same quarter, profit attributable to shareholders of FUPBY and earnings per share stood at €77 million ($84.23 million) and €0.58, up 10% and 16% from the prior-year quarter, respectively.
As of September 30, 2023, FUPBY's current assets stood at €1.37 billion ($1.49 billion), compared to €1.32 billion ($1.44 billion) as of December 31, 2022.
Street expects FUPBY's revenue and EPS in the fiscal year ending December 2023 to increase 6.3% and 14.6% year-over-year to $3.82 billion and $0.57, respectively. The company surpassed consensus revenue estimates in three of the trailing four quarters, which is impressive.
FUPBY's shares have gained 22.3% over the past year to close the last trading session at $10.70. Over the past three months, the stock gained 6.5%.
FUPBY's strong fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. It has an overall rating of A, which equates to a Strong Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
It has an A grade for Stability and a B for Sentiment and Quality. Within the 83-stock <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry, it is ranked #4.
<a href="https://stocknews.com/stock/FUPBY/">Click here</a> to see FUPBY's ratings for Growth, Value, and Momentum.
Stock #2: Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>)
Headquartered in Tokyo, Japan, MTLHY provides performance products, chemicals, industrial materials and gases, health care products, and other products internationally. It is also involved in environmental and recycling-related activities and provides warehousing and semiconductor-related services.
On September 1, MTLHY acquired ISCC PLUS certification, an international certification system for sustainable products that assures that recycled raw materials and biomass raw materials are properly managed in the supply chain, including product manufacturing.
The company pays an annual dividend of $1.10 per share, translating to a dividend yield of 3.40% on the current share price. Its four-year average yield is 4.12%.
MTLHY's trailing-12-month asset turnover ratio of 0.74x is 5.9% higher than the industry average of 0.70x, while its trailing-12-month cash per share of $1.88 is 20.6% higher than the industry average of $1.56.
In the six months that ended September 30, 2023, MTHLY's revenues and gross profit stood at ¥2.15 trillion ($14.54 billion) and ¥562.36 billion ($3.80 billion), respectively. For the same period, net income attributable to owners of the parent and earnings per share stood at ¥67.21 billion ($454.59 million) and ¥45.22, respectively.
As of September 30, 2023, MTLHY's total current assets stood at ¥2.34 trillion ($15.83 billion), compared to ¥2.15 trillion ($14.54 billion) as of March 31, 2023.
For the fiscal third quarter ending December 2023, MTLHY's revenue is expected to be $7.52 billion. Street expects MTLHY's revenue for the fiscal year ending March 2024 to increase significantly year-over-year to $29.54 billion.
The stock has gained 11.5% over the past six months to close its last trading session at $32.27. Over the past year, it has gained 29.2%.
MTLHY's POWR Ratings reflect this promising outlook. The stock has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
MTLHY has a B grade for Value, Stability, and Quality. Within the same industry, it is ranked #3.
To see additional POWR Ratings for Growth, Momentum, and Sentiment for MTLHY, <a href="https://stocknews.com/stock/MTLHY/">click here</a>.
Stock #1: NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>)
NEU manufactures and sells petroleum additives. The company provides lubricant additives for use in various vehicle and industrial applications, engine oil additives, and industrial additives designed for products for industrial applications and industrial specialty applications. It operates in North America, Latin America, the Asia Pacific, Europe, Africa, and India.
On October 26, NEU's board of directors declared a quarterly dividend of $2.25 per share on the company's common stock, payable on January 2, 2024. The company has paid dividends for 16 consecutive years, which justifies its shareholder payback abilities.
Its annualized dividend rate of $9 per share translates to a dividend yield of 1.74% on the current share price. Its four-year average yield is 2.20%. NEU's dividend payments have grown at CAGRs of 4.6% and 4.4% over the past three and five years, respectively.
NEU's trailing-12-month asset turnover ratio of 1.18x is 68.3% higher than the industry average of 0.70x. Its trailing-12-month net income and levered FCF margins of 14.57% and 13.90% are 144.5% and 238.5% higher than the industry averages of 5.96% and 4.11%, respectively.
In the fiscal third quarter that ended September 30, 2023, NEU's net sales stood at $667.15 million, while gross profit increased 36% year-over-year to $201.71 million. For the same quarter, net income and earnings per share stood at $111.25 million and $11.60, up 76% and 83.5% from the prior-year quarter, respectively.
As of September 30, 2023, NEU's total current liabilities stood at $332.20 million, compared to $423.89 million as of December 31, 2022.
The stock has gained 66% year-to-date to close its last trading session at $516.42. Over the past six months, it has gained 29.6%.
NEU's strong outlook is reflected in its POWR Ratings. The stock has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
NEU has a B grade for Stability, Sentiment, and Quality. It is ranked first within the same industry.
Beyond what we have highlighted above, one can see the additional ratings of NEU for Growth, Value, and Momentum <a href="https://stocknews.com/stock/NEU/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
MTLHY shares were unchanged in premarket trading Wednesday. Year-to-date, MTLHY has gained 29.50%, versus a 19.84% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Sristi Suman Jayaswal</h2> <img src='https:/wp-content/uploads/2022/11/Sristi-Suman-Jayaswal_Headshot3.jpg' style="float:left; padding:5px;width:125px;">The stock market dynamics sparked Sristi's interest during her school days, which led her to become a financial journalist. Investing in undervalued stocks with solid long-term growth prospects is her preferred strategy.

Having earned a master's degree in Accounting and Finance, Sristi hopes to deepen her investment research experience and better guide investors.<a href="https://stocknews.com/authors/?author=sristi-sumanjayaswal">More...</a>The post <a href=https://stocknews.com/news/mtlhy-fupby-neu-3-chemical-stocks-to-buy-to-build-up-your-portfolio/>3 Chemical Stocks to Buy to Build up Your Portfolio</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Chemical Stocks to Buy to Build up Your Portfolio

As we step into the new year, the chemical industry presents lucrative investment prospects driven by heightened demand in key end-use sectors, government initiatives, and technological advancements. Hence, fundamentally sound chemical stocks Brenntag (BNTGY), PPG Industries (PPG), and Mitsubishi Chemical Group (MTLHY) might be ideal buys for gains this year and beyond. Read on... A surge in demand from key end-use sectors such as automotive, construction, agriculture, healthcare, and electronics, particularly in emerging markets, is bolstering the chemical industry. So, investors could consider investing in robust chemical stocks Brenntag SE (<a href="https://stocknews.com/stock/BNTGY/">BNTGY</a>), PPG Industries, Inc. (<a href="https://stocknews.com/stock/PPG/">PPG</a>), and Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>) for solid gains this year.
Post-pandemic, government policies such as the Infrastructure Investment and Jobs Act and the Creating Helpful Incentives to Produce Semiconductors and Science Act have injected <a href="https://www2.deloitte.com/us/en/insights/industry/oil-and-gas/chemical-industry-outlook.html">significant funds and incentives</a> into sectors crucial for the energy transition, including electric vehicles, clean energy, semiconductors, lithium-ion batteries, and solar panels.
Despite soft overall chemical demand in 2023, demand for chemicals and materials supporting the energy transition is anticipated to grow in 2024 and beyond due to the positive effects of these initiatives on the economy.
Moreover, continuous innovation and research and development efforts have led to the introduction of novel and environmentally friendly chemical products, providing chemical companies with a competitive edge. On top of it, the chemical industry is leveraging data analytics and AI to gain valuable insights from vast datasets. Also, the concept of digital twins, creating virtual replicas of physical assets and processes, is gaining traction in the chemical industry.
As a result, the global chemical market is anticipated to grow at a <a href="https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report">CAGR of 8.8%</a> until 2032.
Furthermore, the specialty chemicals market is experiencing growth propelled by rising demand for specialty chemicals in the agrochemical sector, recycled plastics, and construction chemicals. The specialty chemicals market is estimated to grow at a <a href="https://www.technavio.com/report/specialty-chemicals-market-industry-analysis">CAGR of 7%</a> until 2027.
With these favorable trends in mind, let's delve into the fundamentals of the three <a href="https://stocknews.com/category/chemicals/">Chemicals</a> stock picks, beginning with the third choice.
Stock #3: Brenntag SE (<a href="https://stocknews.com/stock/BNTGY/">BNTGY</a>)
Based in Essen, Germany, BNTGY purchases and supplies various industrial and specialty chemicals and ingredients internationally. The company operates in two segments, Brenntag Essentials and Brenntag Specialties.
BNTGY's trailing-12-month <a href="https://www.investopedia.com/terms/r/return_on_total_assets.asp">ROTA</a> of 6.52% is 30.6% higher than the industry average of 4.99%, and its trailing-12-month levered FCF margin of 7.14% is 19.4% higher than the industry average of 5,98%.
BNTGY pays $0.44 annually as dividends, which translates to a yield of 1.65% at the current price. Its four-year average dividend yield is 2.21%. The company has raised its dividend payouts at a CAGR of 15.8% over the past three years.
BNTGY's net sales for the fiscal third quarter that ended September 30, 2023, came in at €4.09 billion ($4.51 billion). Profit attributable to BNTGY shareholders and earnings per share came in at €176.30 million ($194.58 million) and €1.18, respectively. The company's free cash flow increased 27% year-over-year to €441.60 million ($487.38 million).
BNTGY's revenue is expected to rise 4.4% year-over-year to $19.48 billion in the fiscal year 2024.
The stock has gained 18.7% over the past three months to close the last trading session at $18.32.
BNTGY's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect its promising outlook. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
The stock has an A grade in Momentum and Stability. It is ranked #17 in the 84-stock <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry.
Click <a href="https://stocknews.com/stock/BNTGY/">here</a> to see the other ratings of BNTGY (Growth, Value, Sentiment, and Quality).
Stock #2: PPG Industries, Inc. (<a href="https://stocknews.com/stock/PPG/">PPG</a>)
PPG manufactures and distributes paints, coatings, and specialty materials worldwide. The company operates through Performance Coatings and Industrial Coatings segments.
PPG's trailing-12-month gross profit of 40.30% is 41.3% higher than the industry average of 28.53%. Its trailing-12-month levered FCF margin of 7.03% is 71.1% higher than the industry average of 4.11%.
On December 12, PPG paid a regular quarterly dividend of 65 cents per share. Its annual dividend of $2.60 yields 1.74% at the current price level. Its four-year average dividend yield is 1.72%. The company has consistently raised its dividend payouts for the past 51 years.
In the fiscal third quarter that ended September 30, 2023, PPG's net sales increased 3.9% year-over-year to $4.64 billion. The adjusted net income and adjusted earnings per share attributable to PPG grew 25.4% and 24.7% from the prior year's quarter to $493 million and $2.07, respectively.
Analysts expect PPG's EPS and revenue to grow 22.4% and 1.9% year-over-year to $1.49 and $4.26 billion in the fiscal fourth quarter ended December 2023. Also, the company topped the consensus EPS estimates in each of the four trailing quarters, which is notable.
Over the past year, the stock has surged 18.3% to close the last trading session at $149.55.
It's no surprise that PPG has an overall rating of B, which equates to Buy in our proprietary rating system.
It has a B grade for Growth, Quality, and Sentiment. Within the same industry, it is ranked #9.
In addition to the POWR Ratings stated above, one can access PPG's ratings for Momentum, Value, and Stability <a href="https://stocknews.com/stock/PPG/">here</a>.
Stock #1: Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>)
Headquartered in Tokyo, Japan, MTLHY provides performance products, chemicals, industrial materials and gases, health care products, and other products internationally. It is also involved in environmental and recycling-related activities and provides warehousing and semiconductor-related services.
MTLHY's trailing-12-month asset turnover ratio of 0.74x is 6% higher than the industry average of 0.70x. Its trailing-12-month cash per share of $1.88 is 20.6% higher than the industry average of $1.56.
The company pays an annual dividend of $1.09 per share, translating to a dividend yield of 3.50% on the current share price. Its four-year average yield is 4.09%.
During the six months that ended September 30, 2023, MTHLY's revenues and gross profit stood at ¥2.15 trillion ($15.24 billion) and ¥562.36 billion ($3.99 billion), respectively. Net income attributable to owners of the parent and earnings per share stood at ¥67.21 billion ($476.42 million) and ¥45.22, respectively.
As of September 30, 2023, MTLHY's total current assets stood at ¥2.34 trillion ($16.59 billion), compared to ¥2.15 trillion ($15.24 billion) as of March 31, 2023.
Street expects MTLHY's revenue for the fiscal year ending March 2024 to increase significantly year-over-year to $31.22 billion.
The stock has gained 5.5% over the past six months to close its last trading session at $31.04. Over the past year, it has soared 20.9%.
MTLHY's POWR Ratings reflect this promising outlook. The stock has an overall rating of A, which translates to a Strong Buy in our proprietary rating system.
MTLHY has a B grade for Value, Stability, and Quality. Within the same industry, it is ranked #3.
To see MTLHY's additional Growth, Momentum, and Sentiment ratings, click <a href="https://stocknews.com/stock/MTLHY/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
PPG shares were trading at $147.39 per share on Tuesday morning, down $2.16 (-1.44%). Year-to-date, PPG has declined -1.44%, versus a -0.72% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Kritika Sarmah</h2> <img src='https:/wp-content/uploads/2022/08/Kritika-Sarmah_Image-3.jpg' style="float:left; padding:5px;width:125px;">Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist. She earned her bachelor's degree in commerce and is currently pursuing the CFA program. With her fundamental approach, she aims to help investors identify untapped investment opportunities.<a href="https://stocknews.com/authors/?author=kritika-sarmah">More...</a>The post <a href=https://stocknews.com/news/ppg-bntgy-mtlhy-3-chemical-stocks-targeting-new-year-gains-and-beyond/>3 Chemical Stocks Targeting New Year Gains and Beyond</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Chemical Stocks Targeting New Year Gains and Beyond

The chemical industry is well-positioned for significant long-term growth thanks to sustained demand across diverse sectors, a shift toward sustainability and green chemistry, and rapid digital transformation. So, it could be wise to invest in top chemical stocks NewMarket (NEU), Mitsubishi Chemical Group (MTLHY), and ChromaDex (CDXC) for substantial gains. Keep reading… Chemicals have extensive application across various industries and, hence, are fundamental to the nation's economy. In addition, ongoing trends such as a growing shift toward sustainability and rapid digitalization and Industry 4.0 would propel the chemical sector's prospects.
Given the industry's bright outlook, it could be ideal to consider investing in fundamentally sound chemical stocks NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>), Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>), and ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>) for accelerating returns.
The U.S. holds a substantial position in the global regime as the world's largest national producer of chemical products. The chemical sector in the U.S. is responsible for <a href="https://www.cisa.gov/sites/default/files/2023-02/chemical_sector_profile_final_508_2022_0.pdf">converting raw materials into more than 70,000 diverse products</a> necessary for modern life; these products are distributed to around 750,000 end users throughout the nation.
The chemical industry accounts for about 25% of the U.S. GDP as it supports the production of almost all commercial and household goods and is essential to economic growth. The employment generations from the chemical market are also significantly contributing to the overall growth of the economy.
The <a href="https://www2.deloitte.com/us/en/insights/industry/oil-and-gas/chemical-industry-outlook.html?id=us:2ps:3gl:chemout24:awa:industryoutlook:011824:chemical%20industry%20outlook:b:c:kwd-298218222617&amp;gad_source=1&amp;gclid=Cj0KCQiAzoeuBhDqARIsAMdH14HsFwgJADITYMg46e-TfYcieCncIA_-WgF13LelP3WQnMdGxcfk0PsaAnk7EALw_wcB">American Chemistry Council</a> expects that capital spending in the U.S. chemical industry will remain stable in 2024 before ramping up to a growth rate of 3% to 4% annually in 2025-2026.
In the near future, the energy transition will generate a wave of manufacturing activities that rely on chemicals and materials for support. Some of the critical factors investigated for 2024 growth are the regional competitive landscape, circular economy, sustainability and trust, and digital and artificial intelligence.
The global chemicals market size is expected to grow from $5.11 trillion in 2023 to $5.57 trillion in 2024 at a CAGR of 9%. Further, the market is anticipated to reach a volume of $7.79 trillion by 2028, <a href="https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report">growing at a CAGR of 8.7%</a>.
The growth in the forecast period is attributable to factors like evolving consumer preferences, renewable and bio-based materials, and health and safety prioritization. Major trends like smart manufacturing and <a href="https://www2.deloitte.com/content/dam/Deloitte/de/Documents/consumer-industrial-products/Deloitte-Industry-4.0-and-the-chemicals-industry.pdf">Industry 4.0</a>, sustainability and green chemistry, and advanced materials and nanotechnology will boost the market's expansion.
In recent years, demand for specialized performance chemicals from the agrochemical industry has been surging. They are used in several applications across the industrial, cosmetics, construction, electronics, and mining sectors. The specialty chemicals market is estimated to total $937.28 billion by 2028, expanding <a href="https://www.thebusinessresearchcompany.com/report/speciality-chemicals-global-market-report">at a CAGR of 4.9%</a>.
In light of these encouraging trends, let's look at the fundamentals of the three best <a href="https://stocknews.com/category/chemicals/">Chemicals</a> stocks, beginning with number 3.
Stock #3: NewMarket Corporation (<a href="https://stocknews.com/stock/NEU/">NEU</a>)
NEU engages in the manufacture and sale of petroleum additives. It provides lubricant additives for use in vehicle and industrial applications, engine oil additives designed for passenger cars, driveline additives for products like transmission fluids, and industrial additives designed for products for industrial applications consisting of hydraulic fluids.
On January 17, NEU completed the acquisition of AMPAC Intermediate Holdings, LLC, the parent company of American Pacific Corporation (AMPAC), for nearly $700 million. Located in Cedar City, Utah, AMPAC is the leading North American manufacturer of critical performance additives used in solid rocket motors for space launch and military defense applications.
"While we remain committed to our core petroleum additives business, we are also committed to identifying terrific opportunities outside of the petroleum additives business that meet our M&amp;A and diversification criteria. We think the acquisition of AMPAC is a great example of that approach," said NEU's Chairman and CEO, Thomas E. Gottwald.
On October 26, NEU's Board of Directors declared a quarterly dividend of $2.25 per share on the common stock of the Corporation. The dividend was paid on January 2, 2024, to NEU's shareholders of record at the close of business on December 15, 2023.
NEU pays an annual dividend of $9, which translates to a yield of 1.53% at the current share price. Its four-year average dividend yield is 2.20%. Moreover, the company's dividend payouts have increased at a CAGR of 5.2% over the past three years. NewMarket has raised its dividends for five consecutive years.
In the fiscal year that ended December 31, 2023, NEU reported a <a href="https://www.investopedia.com/terms/n/netsales.asp">net sales</a> of $2.70 billion. Its income before income tax expense increased 40.6% from the prior year to $488.96 million. Also, its net income grew 39.1% year-over-year to $388.86 million. Its earnings per share came in at $40.44, up 45.6% from the previous year.
As of December 31, 2023, the company's cash and cash equivalents came in at $111.94 million, compared to $68.71 million as of December 31, 2022.
NEU's stock gained 26.1% over the past six months and 63.0% over the past year to close the last trading session at $582.83.
NEU's robust outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
The stock has an A grade for Quality and a B for Stability and Sentiment. NEU is ranked #8 of 84 stocks within the <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry.
To see additional POWR Ratings of NEU for Growth, Value, and Momentum, <a href="https://stocknews.com/stock/NEU/">click here</a>.
Stock #2: Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>)
Headquartered in Tokyo, Japan, MTLHY offers performance products, chemicals, industrial gases, health care products, and other products internationally. It provides polyester films for various applications, industrial materials, and packaging materials for food and other products. It also offers high-performance engineering plastics.
On January 26, MTLHY announced the commencement of full-fledged verification testing for the world's first commercialization of polycarbonate resin chemical recycling. The company is conducting testing to collect polycarbonate resin from the headlamps of end-of-life vehicles.
The testing is being conducted in collaboration with Tokio Marine &amp; Nichido and ABT Corporation.
On January 25, MTLHY announced that its DURABIO&#x2122; plant-derived bioengineering plastic product was chosen by Panasonic Entertainment &amp; Communication Co., Ltd. for its Technics True Wireless Earbuds EAH-AZ80, which were placed on the market on June 15, 2023. The earbuds are the first product in their category to adopt the material.
MTLHY will continue to supply high-value-added performance products through developing DURABIO&#x2122; alongside contributing to the realization of a sustainable society.
For the nine months that ended December 31, 2023, MLTHY reported a sales revenue of ¥3.24 trillion ($21.84 billion). The company's gross profit increased marginally year-over-year to ¥856.04 billion ($5.76 billion). Its operating income grew 337% from the year-ago value to ¥212.50 billion ($1.43 billion).
In addition, the company's net income and EPS came in at ¥144.27 billion ($971.18 million) and ¥69.88, up 222.0% and 505.0% from the prior year's period, respectively.
Analysts expect MTLHY's revenue for the fiscal year (ending March 2024) to increase 3382.8% year-over-year to $30.31 billion. Likewise, the company's revenue for the fiscal year 2025 is expected to grow 2.9% from the prior year to $31.20 billion.
Over the past six months, the stock has gained 1.6% and 11.4% over the past year to close the last trading session at $29.80.
MTLHY's POWR Ratings reflect its bright prospects. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
The stock has an A grade for Value and Stability and a B for Quality. Within the Chemicals industry, MTLHY is ranked #2 out of 84 stocks.
<a href="https://stocknews.com/stock/MTLHY/">Click here</a> to access the other ratings of MTLHY for Growth, Momentum, and Sentiment.
Stock #1: ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>)
CDXC operates as a bioscience company that focuses on developing healthy aging products. It operates through three segments: Consumer Products; Ingredients; and Analytical Reference Standards and Services. The company researches nicotinamide adenine dinucleotide (NAD+) and provides finished dietary supplement products.
On December 12, 2023, CDXC partnered with Neurohacker Collective, an acclaimed American science team that has been formulating advanced nutritional supplements since 2015, to create an NAD+ supplement called Qualia NAD+ that tackles the challenge of boosting NAD+ levels in aging Americans.
ChromaDex Senior Vice President of Business Development, Jason Campbell said: "Created with the highest scientific rigor and quality standards, our patented Niagen NR ingredient is the most efficient precursor available because it can cross the cell membrane directly."
On November 1, CDXC launched its clinical strength Tru Niagen&#xAE; Pro 1,000mg, featuring 1,000mg of Niagen&#xAE; (patented Nicotinamide Riboside or NR), one of the most efficient and superior quality NAD+ precursors on the market, to consumers nationwide.
Tru Niagen&#xAE; Pro 1,000mg is recommended by physicians and is used by pro athletes as a clinically proven alternative to boost NAD+ levels by up to 150% in just three weeks.
During the third quarter that ended September 30, 2023, CDXC's sales increased 14.2% year-over-year to $19.49 million. The company's gross profit rose 17.3% from the year-ago value to $11.97 million. Its adjusted EBITDA came in at $504 thousand, compared to a negative adjusted EBITDA of $1.21 million in the prior year's quarter.
Also, the company's cash and cash equivalents were $26.77 million as of September 30, 2023, compared to $20.44 million as of December 31, 2022.
Street expects CDXC's revenue for the fiscal year (ended December 2023) to grow 15.4% year-over-year to $83.16 million. For the first quarter ending March 2024, its revenue is expected to increase 4.7% year-over-year to $23.62 million. Further, the company has surpassed the consensus EPS estimates in all trailing four quarters, which is remarkable.
Shares of CDXC have surged 5.4% over the past month to close the last trading session at $1.55.
CDXC's sound fundamentals are reflected in its POWR Ratings. The stock has an overall rating of A, which translates to Strong Buy in our proprietary rating system.
CDXC has an A grade for Sentiment and a B for Value and Quality. It is ranked first among 84 stocks in the same industry.
<a href="https://stocknews.com/stock/CDXC/">Click here</a> to access additional CDXC ratings for Growth, Stability, and Momentum.
What To Do Next?
43 year investment veteran, Steve Reitmeister, has just released his 2024 market outlook along with trading plan and top 11 picks for the year ahead.
<a href="https://report.stocknews.com/sign-up/stock-market-outlook-2024/?formplacement=artbotad_smo24_rep">2024 Stock Market Outlook &gt;</a>

<hr />
MTLHY shares were unchanged in premarket trading Tuesday. Year-to-date, MTLHY has declined -0.90%, versus a 3.63% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Mangeet Kaur Bouns</h2> <img src='https:/wp-content/uploads/2022/01/Mangeet-Kaur-Bouns_Image-4.jpg' style="float:left; padding:5px;width:125px;">Mangeet's keen interest in the stock market led her to become an investment researcher and financial journalist. Using her fundamental approach to analyzing stocks, Mangeet's looks to help retail investors understand the underlying factors before making investment decisions.<a href="https://stocknews.com/authors/?author=mangeet-kaurbouns">More...</a>The post <a href=https://stocknews.com/news/mtlhy-neu-cdxc-top-3-accelerating-chemical-stocks-to-consider/>Top 3 Accelerating Chemical Stocks to Consider</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Top 3 Accelerating Chemical Stocks to Consider

Rising demand, emerging technologies, and improved operational efficiency drive the chemical industry's growth. Thus, quality chemical stocks Toray Industries (TRYIY), Mitsubishi Chemical Group (MTLHY), and ChromaDex (CDXC) might be ideal buys now for substantial returns. Read more… The chemical industry is well-positioned for long-term growth thanks to the high demand for specialty chemicals and the integration of digital technology. So, quality chemical stocks Toray Industries, Inc. (<a href="https://stocknews.com/stock/TRYIY/">TRYIY</a>), Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>), and ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>) could be worth buying.
Before delving deeper into their fundamentals, let's discuss what's happening in the chemical industry.
The American Chemistry Council (ACC) U.S. Chemical Production Regional Index (U.S. CPRI) <a href="https://www.americanchemistry.com/chemistry-in-america/news-trends/weekly-economic-report/2024/weekly-chemistry-and-economic-trends-march-22-2024">increased by 0.4% in February</a>, following a 0.1% drop in January. Compared to February of the previous year, output increased by 2.0%, with year-over-year growth across all regions (excluding the Northeast).
The global chemicals market is expected to be worth $982.20 billion by 2030, registering a <a href="https://www.verifiedmarketresearch.com/product/chemical-industry-market/">CAGR of 4.8%</a>. The rising demand for inorganic chemicals in the fertilizer industry is expected to propel the chemicals market forward, as these chemicals improve plant growth and productivity.
The agrochemical industry's demand for specialized performance chemicals has increased significantly in recent years. They have a wide range of applications in sectors such as manufacturing, cosmetics, construction, electronics, and mining. The specialty chemicals market is estimated to total $762.08 billion by 2030, expanding at a <a href="https://www.nextmsc.com/report/specialty-chemicals-market">CAGR of 4.4%</a>.
In light of these encouraging trends, let's examine the fundamentals of the three <a href="https://stocknews.com/category/chemicals/">Chemicals</a> stocks, beginning with the third pick.
Stock #3: Toray Industries, Inc. (<a href="https://stocknews.com/stock/TRYIY/">TRYIY</a>)
Headquartered in Tokyo, Japan, TRYIY, together with its subsidiaries, manufactures, processes, and sells fibers and textiles, performance chemicals, carbon fiber composite materials, environment and engineering products, and life science products in Japan, China, North America, Europe, and internationally.
TRYIY's forward <a href="https://www.investopedia.com/terms/e/enterprisevaluesales.asp">EV/Sales</a> of 0.79x is 51.5% lower than the industry average of 1.63x. Its forward Price/Sales multiple of 0.46 is 63.4% lower than the industry average of 1.27.
TRYIY's trailing-12-month asset turnover ratio of 0.73x is 5.5% higher than the 0.69x industry average.
For the nine months ended December 31, 2023, TRYIY's revenues stood at ¥1.83 trillion ($12.09 billion), while its operating income came in at ¥71.37 billion ($471.68 million). Its profit and EPS came in at ¥45.66 billion ($301.76 million) and ¥28.46, respectively.
Also, its total assets came in at ¥3.39 trillion ($22.39 billion) for the period that ended December 31, 2023, compared to ¥3.19 trillion ($21.11 billion) for the period that ended March 31, 2023.
For the quarter ending June 30, 2024, TRYIY's revenue is expected to increase marginally year-over-year to $4.07 billion. Over the past month, the stock has gained 5.8% to close the last trading session at $9.71.
TRYIY's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect this promising outlook. It has an overall rating of A, equating to a Strong Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
TRYIY has an A grade for Stability and a B for Growth, Value, and Momentum. Within the B-rated <a href="https://stocknews.com/category/chemicals/">Chemicals</a> industry, it is ranked #3 out of 82 stocks. To see the additional ratings of TRYIY for Sentiment and Quality, <a href="https://stocknews.com/stock/TRYIY/">click here</a>.
Stock #2: Mitsubishi Chemical Group Corporation (<a href="https://stocknews.com/stock/MTLHY/">MTLHY</a>)
Headquartered in Tokyo, Japan, MTLHY offers performance products, chemicals, industrial gasses, health care products, and other products internationally. It provides polyester films for various applications, industrial and packaging materials for food and other products. It also offers high-performance engineering plastics.
MTLHY's forward EV/EBITDA of 6.79x is 19.4% lower than the industry average of 8.43x. Its forward Price/Sales multiple of 0.30 is 76.1% lower than the industry average of 1.27.
MTLHY's trailing-12-month levered FCF margin of 6.40% is 22.7% higher than the 5.21% industry average. Its trailing-12-month Return on Common Equity of 11.44% is 77.2% higher than the 6.46% industry average. Additionally, its 6.99% trailing-12-month Return on Total Capital is 38.4% higher than the 5.06% industry average.
For the nine months that ended December 31, 2023, MTLHY reported a sales revenue of ¥3.24 trillion ($21.84 billion). The company's gross profit increased marginally year-over-year to ¥856.04 billion ($5.76 billion). Its operating income grew 337% from the year-ago value to ¥212.50 billion ($1.43 billion).
In addition, the company's net income and EPS came in at ¥144.27 billion ($971.18 million) and ¥69.88, up 222.0% and 505.0% from the prior-year period, respectively.
Street expects MTLHY's revenue for the year ending March 31, 2024, to increase significantly year-over-year to $28.97 billion. Over the past month, the stock has gained 10.1% to close the last trading session at $30.90.
MTLHY's strong fundamentals are reflected in its POWR Ratings. It has an overall rating of A, which equates to a Strong Buy in our proprietary rating system.
It is ranked #2 in the same industry. It has an A grade for Value and Stability and a B for Growth and Quality. <a href="https://stocknews.com/stock/MTLHY/">Click here</a> to see the additional ratings of MTLHY for Momentum and Sentiment.
Stock #1: ChromaDex Corporation (<a href="https://stocknews.com/stock/CDXC/">CDXC</a>)
CDXC operates as a bioscience company that focuses on developing healthy aging products. It has three segments: Consumer Products; Ingredients; and Analytical Reference Standards and Services. The company researches nicotinamide adenine dinucleotide (NAD+) and provides finished dietary supplement products.
CDXC's forward EV/Sales of 2.74x is 25.3% lower than the industry average of 3.66x. Its forward Price/Sales multiple of 2.99 is 22.2% lower than the industry average of 3.83.
CDXC's trailing-12-month gross profit margin of 60.76% is 6.7% higher than the industry average of 56.93%. Its 11.33% trailing-12-month levered FCF margin is significantly higher than the 0.78% industry average. Its 1.53x trailing-12-month asset turnover ratio is 291.2% higher than the 0.39x industry average.
During the fourth quarter that ended December 31, 2023, CDXC's sales increased marginally year-over-year to $21.20 million. The company's gross profit rose 7.7% from the year-ago value to $12.94 million. Its adjusted EBITDA came in at $1.25 million, an increase of 256.3% year-over-year.
Also, the company's cash and cash equivalents were $27.33 million as of December 31, 2023, compared to $20.44 million as of December 31, 2022.
Analysts expect CDXC's EPS for the year ending December 31, 2025, to increase significantly year-over-year to $0.06. Its revenue is expected to grow 17.7% year-over-year to $114.28 million for the same period. CDXC shares have gained 168.5% over the past six months, closing the last trading session at $3.84.
It's no surprise that CDXC has an overall A rating, equating to a Strong Buy in our POWR Ratings system.
It has an A grade for Quality and a B for Growth and Sentiment. It is ranked first in the Chemicals industry.
Beyond what is stated above, we've also rated CDXC for Value, Momentum, and Stability. Get all CDXC ratings <a href="https://stocknews.com/stock/CDXC/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
MTLHY shares were trading at $30.90 per share on Wednesday afternoon, up $0.17 (+0.54%). Year-to-date, MTLHY has gained 2.76%, versus a 9.65% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rashmi Kumari</h2> <img src='https:/wp-content/uploads/2022/10/Rashmi-Kumari_headshot_2-1.jpg' style="float:left; padding:5px;width:125px;">Rashmi is passionate about capital markets, wealth management, and financial regulatory issues, which led her to pursue a career as an investment analyst. With a master's degree in commerce, she aspires to make complex financial matters understandable for individual investors and help them make appropriate investment decisions.<a href="https://stocknews.com/authors/?author=rashmi-kumari">More...</a>The post <a href=https://stocknews.com/news/mtlhy-tryiy-cdxc-3-chemical-stocks-poised-for-gains/>3 Chemical Stocks Poised for Gains</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Comments

Mitsubishi Chemical Group

매도 수량

Mitsubishi Chemical Group (OTC:MTLHY) 주식, 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌